← FDA Drug Approvals (Drugs@FDA)

MIDAZOLAM IN 0.9% SODIUM CHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HIKMA · Approved 2023-04-17

Drug application

FDA Application #

ANDA216159

Application type

Abbreviated New Drug Application (Generic)

Brand name

MIDAZOLAM IN 0.9% SODIUM CHLORIDE

Generic name

MIDAZOLAM IN SODIUM CHLORIDE

Active ingredients

MIDAZOLAM

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

HIKMA

Manufacturer

Hikma Pharmaceuticals USA Inc.

First approval

2023-04-17

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown